Site-Specific Evolutionary Rate Shifts in HIV-1 and SIV

Viruses
Maoz Gelbart, Adi Stern

Abstract

Site-specific evolutionary rate shifts are defined as protein sites, where the rate of substitution has changed dramatically across the phylogeny. With respect to a given clade, sites may either undergo a rate acceleration or a rate deceleration, reflecting a site that was conserved and became variable, or vice-versa, respectively. Sites displaying such a dramatic evolutionary change may point to a loss or gain of function at the protein site, reflecting adaptation, or they may indicate epistatic interactions among sites. Here, we analyzed full genomes of HIV and SIV-1 and identified 271 rate-shifting sites along the HIV-1/SIV phylogeny. The majority of rate shifts occurred at long branches, often corresponding to cross-species transmission branches. We noted that in most proteins, the number of rate accelerations and decelerations was equal, and we suggest that this reflects epistatic interactions among sites. However, several accessory proteins were enriched for either accelerations or decelerations, and we suggest that this may be a signature of adaptation to new hosts. Interestingly, the non-pandemic HIV-1 group O clade exhibited a substantially higher number of rate-shift events than the pandemic group M clade. We propose ...Continue Reading

References

Jan 1, 1985·Journal of Molecular Evolution·M HasegawaT Yano
Mar 15, 1997·AIDS·M PeetersE Delaporte
Jun 10, 2000·Science·B KorberT Bhattacharya
Apr 25, 2001·Molecular Biology and Evolution·N Galtier
Dec 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·B Knudsen, M M Miyamoto
Dec 26, 2001·Molecular Biology and Evolution·P LopezH Philippe
Jun 14, 2003·Science·Elizabeth BailesPaul M Sharp
Jul 29, 2004·Genetics·Philippe LemeyAnne-Mieke Vandamme
Jul 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ari Löytynoja, Nick Goldman
Nov 10, 2006·Nature·Fran Van HeuverswynMartine Peeters
Jun 5, 2007·Molecular Biology and Evolution·Louise V WainPaul M Sharp
Jan 18, 2008·Nature·Stuart J D NeilPaul D Bieniasz
Nov 8, 2008·PLoS Computational Biology·Osnat PennTal Pupko
Dec 17, 2008·Journal of Virology·Jun TakehisaBeatrice H Hahn
May 5, 2009·PLoS Computational Biology·Joel O Wertheim, Michael Worobey
May 16, 2009·Nucleic Acids Research·Anne-Kathrin SchultzMario Stanke
Jun 9, 2009·Cell Host & Microbe·Fengwen ZhangTheodora Hatziioannou
Aug 7, 2010·Trends in Microbiology·David T EvansJohn C Guatelli
Oct 1, 2011·Retrovirology·Su Jung YangPaula M Cannon
May 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·David D PollockRichard A Goldstein
Jul 28, 2012·Journal of Virology·Yingying LiBeatrice H Hahn
Oct 16, 2012·Nature·Michael S BreenFyodor A Kondrashov
Jul 23, 2013·Cell Host & Microbe·Lucie EtienneMichael Emerman
Nov 7, 2014·PLoS Pathogens·Ben LongdonFrancis M Jiggins
Jan 1, 2015·EMBO Molecular Medicine·Almudena Marí SaézFabian H Leendertz
Mar 4, 2015·Proceedings of the National Academy of Sciences of the United States of America·Mirela D'arcMartine Peeters
Jun 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·Premal ShahJoshua B Plotkin
Aug 5, 2015·PLoS Pathogens·Marie LeozJean-Christophe Plantier
Feb 3, 2016·Protein Science : a Publication of the Protein Society·Tyler N Starr, Joseph W Thornton

❮ Previous
Next ❯

Citations

Jul 30, 2021·Protein Science : a Publication of the Protein Society·Noor YoussefJoseph P Bielawski

❮ Previous
Next ❯

Software Mentioned

PhyML
PRANK
RASER
JpHMM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.